Skip to main content
. 2023 Nov 4;7(8):102248. doi: 10.1016/j.rpth.2023.102248

Table 3.

Inhibitor and anti–factor IX immunoglobulin G1 titers in hemophilia B mice that received 0.01 to 1 IU of FIX-Fc intradermally + intraperitoneally/intravenously.

Animal group 1 IU FIX IP/i.v. 0.01 IU FIX-Fc ID + IP/i.v. 0.1 IU FIX-Fc ID + IP/i.v. 1 IU FIX-Fc ID + IP/i.v.
Inhibitor (BU/mL), mean ± SD 0.8 ± 0.7 0.8 ± 1.1 8.4 ± 8.7 41.9 ± 28.1
IgG1 (μg/mL), mean ± SD 72.9 ± 100.8 144.5 ± 115.5 351.4 ± 177.0 516.3 ± 311.7

BU, Bethesda unit; FIX, factor IX; ID, intradermally; IP, intraperitoneal; i.v., intravenous.